Elevated levels of the soluble form of bone marrow stromal cell antigen 1 in the sera of patients with severe rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 4, 1996, Pages 629-637

  Lee, Byung Ok ^a   Ishihara, Katsuhiko ^a   Denno, Kakuro ^a   Kobune, Yoshiko ^a   Itoh, Motoyuki ^a   Muraoka, Osamu ^a   Kaisho, Tsuneyasu ^a   Sasaki, Takeshi ^b   Ochi, Takahiro ^a   Hirano, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW STROMAL CELL ANTIGEN 1; C REACTIVE PROTEIN; CELL ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS;

ADP-RIBOSYL CYCLASE; ADULT; ANTIGENS, CD; ANTIGENS, SURFACE; ARTHRITIS, RHEUMATOID; BONE MARROW; CELL LINE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; STROMAL CELLS; SYNOVIAL MEMBRANE;

EID: 0001236158     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390414     Document Type: Article

References (33)

1. Lipsky PE: Rheumatoid arthritis. In, Harrison's Principles of Internal Medicine. Twelfth edition. Edited by JD Wilson, E Braunwald, KJ Isselbacher, RG Petersdorf, JB Martin, AS Fauci, RK Root. New York, McGraw-Hill, 1991
2. Hirano T: Interleukin 6 and autoimmunity and plasma cell neoplasias. Res Immunol 143:759-763, 1992
3. Wicks I, McColl G, Harrison L: New perspectives on rheumatoid arthritis. Immunol Today 15:533-556, 1994
4. Hirano T, Matsuda T, Kato K, Buchang G, Tang B, Miyasaka N, Shimizu M, Maini R, Feldmann M, Kishimoto K: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18:1797-1801, 1988
5. Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160, 1995
6. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, Fujita K, Lipsky PE: Elevated interteukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 38:96-104, 1995
7. Dechanet J, Merville P, Durand I, Banchereau J, Miossec P: The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest 95:456-463, 1995
8. Kincade PW: Molecular interactions between stromal cells and B lymphocyte precursors. Semin Immunol 3:379-390, 1991
9. Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Shimierer A, Mosley B, March CJ, Urdal D, Gillis D, Cosman D, Goodwin RG: Stimulation of B cell progenitors by cloned murine interleukin 7. Nature 333:571-573, 1988
10. Witte ON: Steel locus defines new multipotent growth factor. Cell 63:5-6, 1990
11. McNiece IK, Langley KE, Zsebo KM: The role of recombinant stem cell factor in early B cell development: synergistic interaction with IL-7. J Immunol 146:3785-3790, 1991
12. Gimble JM, Pietrangeli C, Henley A, Dorheim MA, Silver J, Namen A, Takeichi M, Goridis C, Kincade PW: Characterization of murine bone marrow and spleen-derived stromal cells: analysis of leukocyte marker and growth factor mRNA transcript levels. Blood 74:303-311, 1989
13. Hirayama F, Shih JP, Awgulewitsch A, Warr GW, Clark SC, Ogawa M: Clonal proliferation of murine lymphohematopoietic progenitors in culture. Proc Natl Acad Sci U S A 89:5907-5911, 1992
14. Kaisho T, Oritani K, Isikawa J, Tanabe M, Muraoka O, Ochi T, Hirano T: Human bone marrow stromal cell lines from myeloma and rheumatoid arthritis that can support murine pre-B cell growth. J Immunol 149:4088-4095, 1992
15. Kaisho T, Ishikawa J, Oritani K, Inazawa J, Tomizawa H, Muraoka O, Ochi T, Hirano T: BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B cell growth. Proc Natl Acad Sci U S A 91:5325-5329, 1994
16. Itoh M, Ishihara K, Tomizawa H, Tanaka H, Kobune Y, Ishikawa J, Kaisho T, Hirano T: Molecular cloning of murine BST-1 having homology with CD38 and aplysia ADP-ribosyl cyclase. Biochem Biophys Res Commun 203:1309-1317, 1994
17. Dong C, Wang J, Neame P, Cooper MD: The murine BP-3 gene encodes a relative of the CD38/NAD glycohydrolase family. Int Immunol 6:1353-1360, 1994
18. Hirata Y, Kimura N, Sato K, Ohsugi Y, Takasawa S, Okamoto H, Ishikawa J, Kaisho T, Ishihara K, Hirano T: ADP-ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1. FEBS Lett 356:244-248, 1994
19. Lee HC, Galione A, Walseth TF: Cyclic ADP-ribose: metabolism and calcium mobilizing function. Vitam Horm 48:199-257, 1994
20. Bazil V: Physiological enzymatic cleavage of leukocyte membrane molecule. Immunol Today 16:135-140, 1995
21. Gearing AJ, Newman W: Circulating adhesion molecules in disease. Immunol Today 14:506-512, 1993
22. Huizinga TW, de Hass M, Kleijer M, Nuijens JH, Roos D, von dem Borne AE: Soluble Fcγ receptor III in human plasma originates from release by neutrophils. J Clin Invest 86:416-423, 1990
23. Fridman WH, Teillaud JL, Bouchard C, Teillaud C, Astier A, Tartour E, Galon J, Mathiot C, Sautes C: Soluble Fcγ receptor. J Leukoc Biol 54:504-512, 1993
24. Keystone EC, Snow KM, Bombardier C, Chang C-H, Nelson DL, Rubin LA: Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 31:844-849, 1988
25. Martin S, Rieckmann P, Melchers I, Wagner R, Bertrams J, Voskuyl AE, Roep BO, Zielasek J, Heidenthal E, Weichselbraun I, Gallatin WM, Kolb H: Circulating forms of ICAM-3 (cICAM-3). J Immunol 154:1951-1955, 1995
26. Pino-Otin MR, Vinas O, de la Fuente MA, Juan M, Font J, Torrndeflot M, Pallares L, Lozano F, Alberola-Ila J, Martorell J, Yague J, Vires J, Gaya A: Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte acivation. J Immunol 154:3015-3024, 1995
27. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M: Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 35:1160-1169, 1992
28. Barrera P, Boerbooms AMT, Janssen EM, Sauerwein RW, Gallati H, Mulder J, de Boo T, Demacker PNM, van de Putte LB, van der Meer JWM: Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis: longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 36:1070-1079, 1993
29. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
30. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
31. Ochi T, Iwase R, Yonemasu K, Matsukawa M, Yoneda M, Yukioka M, Ono K: Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arhritis. Arthritis Rheum 31:37-43, 1988
32. Matsuda T, Yamanaka Y. Hirano T: Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells. Biochem Biophys Res Commun 200:821-828, 1994
33. Metz CN, Brunner G, Choi-Muira NH, Nguyen H, Gabrilove J, Caras IW, Altszuler N, Rifkin DB, Wilson EL, Davitz MA: Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 13:1741-1751, 1994